Exploring The Relationship between FOXP3⁺ Regulatory T Cells, Eosinophilia, and Disease Severity in Chronic Rhinosinusitis with Nasal Polyps
DOI:
https://doi.org/10.31436/imjm.v25i02.3376Keywords:
Chronic rhinosinusitis, Eosinophilic, T regulatory cells, Nasal polyps, ImmunohistochemistryAbstract
INTRODUCTION: Chronic Rhinosinusitis (CRS) is a common condition causing a significant worldwide burden, affecting 5%-12% of the general population. The immunoregulatory mechanisms underlying eosinophilic and non-eosinophilic CRS with polyps (CRSwNP) remain incompletely understood, particularly with respect to regulatory T cells, FOXP3⁺. MATERIALS AND METHODS: Using immunohistochemistry, nasal polyp tissues from eosinophilic (ECRS) and non-eosinophilic (NECRS) CRSwNP patients were examined for FOXP3⁺ Treg expression, and symptoms and disease severity measures were obtained, including on quality of life. RESULTS: Comparative analysis along with clinical severity assessment did not demonstrate significant differences between eosinophilic and non-eosinophilic CRSwNP in FOXP3⁺ score (5.14 vs. 4.81, p=0.453), nasal polyp score (p=0.315), SNOT-22 (p=0.510), SST (p=0.295), or VAS (p=0.182), with small to medium effect sizes (Cohen’s d=0.25-0.50). Correlation analysis revealed no significant associations between FOXP3⁺ expression and clinical parameters, although SST showed a weak inverse association (ρ= –0.335, p=0.070). Significant correlations were observed between VAS and SNOT-22 (ρ= –0.549, p=0.0017) and between SNOT-22 and SST (ρ= –0.470, p=0.0088), indicating consistency between subjective and objective measures. CONCLUSION: These findings suggest that FOXP3⁺ regulatory T cell infiltration alone may not distinguish CRSwNP endotypes, underscoring the complexity of immune regulation beyond eosinophilic status. Larger, functionally focused studies are required to further elucidate the role of Tregs in CRSwNP.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
All material submitted for publication is assumed to be submitted exclusively to the IIUM Medical Journal Malaysia (IMJM) unless the contrary is stated. Manuscript decisions are based on a double-blinded peer review process. The Editor retains the right to determine the style and if necessary, edit and shorten any material accepted for publication.
IMJM retain copyright to all the articles published in the journal. All final ‘proof’ submissions must be accompanied by a completed Copyright Assignment Form, duly signed by all authors. The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.
